Speech Drug Pricing & Drug Access

Drug Pricing & Drug Access

Recent announcements around the CMS 340B program have made oncology programs anxious about reimbursement costs. ECG’s Jessica Turgeon will moderate a panel addressing issues around cancer drug pricing and accessibility under the new rules.

ECG is proud to be a sponsor of the ACCC 44th Annual Meeting & Cancer Center Business Summit.

Discussion Panel

Jessica Turgon, MBA
ECG Management Consultants

Allen S. Lichter, MD, FASCO
Value in Cancer Care Consortium

Ira Klein, MD, MBA, FACP
Janssen Pharmaceuticals